Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
FENOLDOPAM - A NEW DOPAMINE AGONIST FOR THE TREATMENT OF HYPERTENSIVEURGENCIES AND EMERGENCIES
Autore:
POST JB; FRISHMAN WH;
Indirizzi:
1825 EASTCHESTER RD BRONX NY 10461 MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DEPT MED BRONX NY 10467
Titolo Testata:
Journal of clinical pharmacology
fascicolo: 1, volume: 38, anno: 1998,
pagine: 2 - 13
SICI:
0091-2700(1998)38:1<2:F-ANDA>2.0.ZU;2-A
Fonte:
ISI
Lingua:
ENG
Soggetto:
SEVERE SYSTEMIC HYPERTENSION; CONGESTIVE-HEART-FAILURE; DA1 RECEPTOR AGONIST; BLOOD-PRESSURE REDUCTION; INTRAVENOUS FENOLDOPAM; SODIUM-NITROPRUSSIDE; F 82526; INTRAOCULAR-PRESSURE; RENAL VASODILATORS; ANESTHETIZED DOG;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
65
Recensione:
Indirizzi per estratti:
Citazione:
J.B. Post e W.H. Frishman, "FENOLDOPAM - A NEW DOPAMINE AGONIST FOR THE TREATMENT OF HYPERTENSIVEURGENCIES AND EMERGENCIES", Journal of clinical pharmacology, 38(1), 1998, pp. 2-13

Abstract

Fenoldopam is a selective dopamine agonist that is being considered for the parenteral treatment of systemic hypertension. In both an oral and parenteral form, the drug causes peripheral vasodilation by stimulating dopamine-1 adrenergic receptors. Its pharmaco-dynamics are reviewed in this article, along with the clinical experiences in patients with hypertensive urgencies and emergencies. Intravenous fenoldopam mayprovide advantages over sodium nitroprusside because it can induce both a diuresis and natriuresis, is not light sensitive, and is not associated with cyanide toxicity. There is no evidence for rebound hyper tension after discontinuation of fenoldopam influsion.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/07/20 alle ore 01:48:18